Clinical Trial

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
In this clinical trial, the safety, tolerability, and preliminary antitumor activity of ziftomenib in combination with imatinib will be evaluated in adults with gastrointestinal stromal tumors (GIST) who have been treated previously with imatinib.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2024-10-22; most recent amendment 2026-02-03.
Status change: Not Yet Recruiting → Recruiting 2025-04-15
Trial Details
NCT Number NCT06655246
Lead Sponsor Kura Oncology, Inc.
Conditions Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Stromal Cancer, Gastrointestinal Stromal Neoplasm, Gastrointestinal Stromal Tumor, Malignant, Gastrointestinal Stromal Cell Tumors
Enrollment 157 participants
Start Date 2025-03-27
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-05